Mucitus 150mg 12 capsules — Made in India — Free Delivery

Product description

Mucitus capsules are indicated for use:

• to reduce the viscosity and facilitate the expectoration of bronchial secretions in the treatment of acute and chronic diseases of the upper and lower respiratory tract, such as bronchitis, rhinitis, sinusitis, laryngopharyngitis, exacerbation of chronic bronchitis, chronic obstructive pulmonary disease (COPD), hypersecretory bronchial asthma, bronchiectasis;
• to prevent recurrence of episodes of infections and complications after surgery, such as pneumonia or partial pulmonary atelectasis;
• as concomitant therapy with antibiotics in case of bacterial respiratory tract infections.

Composition

The active ingredient is erdosteine ​​(one capsule contains 150 mg erdosteine).

Excipients: microcrystalline cellulose, povidone, sodium starch glycolate (type A), magnesium stearate; capsule shell: brilliant blue (E 133), carmoisin (E 122), quinoline yellow (E 104), titanium dioxide (E 171), gelatin.

Contraindications

Hypersensitivity to the active substance or to any of the excipients containing free SH-groups.

You should stop using this preparation if:

• with liver disorders (for example, with an increase in serum alkaline phosphatase or transaminase levels);
• with renal failure (creatinine clearance <25 ml / minute);
• with homocystinuria (this preparation is a source of homocysteine, and now there is no available data on the use of erdosteine ​​in the case of congenital disorders of amino acid metabolism, especially in patients who are forced to follow a methionine-free diet);
• with peptic ulcer in the active phase.

Mode of application

The preparation is administered orally, regardless of food intake.

Recommended dosage:

• children aged 8 to 12 years - 150 mg 2 times a day;
• adults and children over 12 years old - 300 mg 2 times a day.

The course of treatment is determined by the doctor individually. In acute uncomplicated diseases, the preparation should be used for 5-10 days. The duration of treatment for chronic diseases is determined by the doctor. Elderly patients do not need dose adjustment.

Application features

Pregnant

During the studies, no cases of embryo / fetal malformations were identified, however, information on the use of erdosteine ​​during pregnancy and lactation is limited. In this regard, the preparation should be used during pregnancy, especially during the first trimester, only if absolutely necessary, after assessing the benefits / risks to the fetus and mother.

Children

The preparation is contraindicated in children under the age of 8 years.

Drivers

There was no negative effect on the ability to drive vehicles, operate machinery or concentrate.

Overdose

So far, no cases of overdose have been reported. In case of an overdose or accidental intake of this remedy, the child is recommended symptomatic therapy (gastric lavage and other supportive measures).

Side effects

Sometimes the use of erdosteine ​​can cause undesirable reactions from the gastrointestinal tract, such as a burning sensation and pain in the stomach, nausea, vomiting, and rarely, diarrhea. In several cases, ageusia or dysgeusia were observed at the beginning of therapy. Hypersensitivity reactions such as rash or sudden hyperpyrexia, erythema, Quincke's edema are rare. From the side of the nervous system, headache is possible.

Storage conditions

Store in its original packaging at a temperature not exceeding 30 ° C, out of the reach of children.

Shelf life is 2 years.